Bayer Aktiengesellschaft (OTCPK:BAYZF) Q3 2023 Earnings Conference Call November 8, 2023 8:00 AM ET Company Participants Jost Reinhard - Senior Vice President & Head-Investor Relations Bill Anderson - Chief Executive Officer Wolfgang Nickl - Chief Financial Officer Rodrigo Santos - President, Crop Science Division Stefan Oelrich - President, Pharmaceuticals Division Heiko Schipper - President, Consumer Health Division Conference Call Participants Peter Verdult - Citi Sachin Jain - Bank of America Vincent An ...

Bayer Aktiengesellschaft (OTCPK:BAYZF) Q2 2023 Earnings Call Transcript August 8, 2023 8:00 AM ET Company Participants Oliver Maier - Head of IR Bill Anderson - CEO Wolfgang Nickl - CFO Rodrigo Santos - President, Crop Science Division Stefan Oelrich - President, Pharmaceuticals Division Heiko Schipper - President, Consumer Health Division Conference Call Participants Michael Leuchten - UBS Richard Vosser - JPMorgan James Quigley - Morgan Stanley Peter Verdult - Citigroup Sachin Jain - Bank of America Vince ...

| --- | --- | --- | --- | |--------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | Q2 2023 | | | | | Investor Call //////////////// | | | | | August 8th, 2023 | | | | Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the act ...

| --- | --- | --- | --- | |----------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | Investor Conference Call Q1 2023 //////////////// | | | | | May 11th, 2023 | | | | Cautionary Statements Regarding Forward-Looking Information | --- | --- | --- | |-------|--------------------------------|-------| | | | | | | | | | | | | | | | | | | The company assumes no | | | | | | | | | | | | liability whatsoever to update | | | | | | | | | | | | these forward-looking | ...

Bayer AG (OTCPK:BAYZF) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Oliver Maier - Head of Investor Relations Werner Baumann - Chief Executive Officer Stefan Oelrich - Head, Pharmaceuticals Division Rodrigo Santos - Head, Crop Science Division Conference Call Participants Michael Leuchten - UBS Richard Vosser - JPMorgan James Quigley - Morgan Stanley Christian Faitz - Kepler Cheuvreux Kirsty Ross-Stewart - Citi Joe Bowden - Bank of America Jo Walton - Credit Suisse Andreas H ...

Bayer AG (OTCPK:BAYZF) Q4 2022 Results Earnings Conference Call February 28, 2023 8:00 AM ET Company Participants Oliver Maier - Head of Investor Relations Werner Baumann - Chairman, Chief Executive Officer and Chief Sustainability Officer Rodrigo Santos - President, Crop Science Division Stefan Oelrich - Head, Pharmaceuticals Division Heiko Schipper - President, Consumer Health Division Wolfgang Nickl - Chief Financial Officer Conference Call Participants Michael Leuchten - UBS James Quigley - Morgan Stanl ...

/////////// Investor Conference Call FY/Q4 2022 Results February 28th, 2023 Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include ...

Quarterly Statement Third Quarter of 2022 Bayer with continued strong performance // Group sales at €11.3 billion (Fx & p adj. + 5.7%) // EBITDA before special items rises significantly to €2.5 billion (+ 17.3%) // Crop Science achieves strong sales gains; sales also up at Pharmaceuticals and Consumer Health // All divisions report significant increase in earnings // Core earnings per share at €1.13 (+ 7.6%) // Net income at €0.5 billion // Free cash flow at €1.7 billion // Major progress in Pharmaceuticals ...

/////////// Investor Conference Call Q2 2022 Results August 4th, 2022 Werner Baumann, CEO Wolfgang Nickl, CFO Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates ...

Science for a Better Life A Global Leader in Health & Nutrition /////////// BMO Global Farm to Market Conference May 2022 / Bayer AG 1 /// Bayer AG /// BMO Global Farm to Market Conference /// May 2022 Cautionary Statements Regarding Forward-Looking Information This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual futur ...